4D Molecular Therapeutics Inc (FDMT)
EBITDA Margin
-1977.52%
Quarterly · Period ending:
FDMT EBITDA Margin
Latest reported-1977.52%period ending
Latest reported-1977.52%period ending
FDMT Quarterly EBITDA Margin (-98.56% → -1977.52%)
Quarterly ebitda margin
High-resolution chart · PNG
FDMT ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -1,977.5192% | |
| -2,189.2025% | |
| 14.5564% | |
| -60,970% | |
| -351,800% | |
| -330,128.5714% | |
| -4,788,700% | |
| -1,404,666.6667% | |
| -666,580% | |
| -110,025% | |
| 161,947.3684% | |
| -43.8527% | |
| -11,794.1423% | |
| -9,151.0067% | |
| -2,084.2823% | |
| -4,962.4% | |
| -16,824.0741% | |
| -2,096.4725% | |
| -24,873.913% | |
| -1,572.4012% | |
| -46.9616% | |
| -796.55% | |
| 2,052.303% | |
| -100.3504% | |
| -407.1016% | |
| -365.8557% | |
| -786.6995% | |
| -2,149.2593% | |
| -386.0281% | |
| -386.0281% | |
| -51.9369% | |
| -51.9369% | |
| -98.5599% | |
| -98.5599% |